With 7.76 million shares changed hands, the volume of the stock remained heavier than its average volume of 5.36 million shares. The 52-week range on CLOV shows that it touched its highest point at $4.87 and its lowest point at $0.61 during that stretch. It currently has a 1-year price target of $4.67. Beta for the stock currently stands at 2.00.
Price Performance and Earnings:
Stock performance is one of the indicators that investors use to determine whether they will profit from a stock. The price performance of CLOV was down-trending over the past week, with a drop of -3.08%, but this was up by 2.09% over a month. Three-month performance surged to 37.07% while six-month performance rose 41.94%. The stock gained 360.15% in the past year, while it has gained 39.68% so far this year. A look at the trailing 12-month EPS for CLOV yields -0.19 with Next year EPS estimates of -0.14. For the next quarter, that number is -0.07. This implies an EPS growth rate of 73.20% for this year and -16.51% for next year. EPS is expected to grow by 46.63% annually over the next five years; however, over the past five years, the company experienced an annual growth rate of -585.84%.
Float and Shares Shorts:
At present, 394.44 million CLOV shares are outstanding with a float of 376.52 million shares on hand for trading.
Analysts Ratings:
Reading analyst opinions is an effective way to decide where to invest, and there are several opinions available for CLOV since 1 analysts follow the stock currently. There are 0 analysts who recommend BUY ratings, while 0 suggest SELL ratings. Of the remaining analysts, 1 believe that the stock is worth HOLDING, 0 give it an OVERWEIGHT rating, and 0 thinks that it’s UNDERWEIGHT. In the same way, a target price assigned to a stock can also reveal much about its potential.
EPS: Estimates vs Actual
It is also common to use earnings estimates to evaluate a firm’s growth potential and to determine trading strategy. Analysts have provided yearly estimates in a range of -$0.11493 being high and -$0.12445 being low. For CLOV, this leads to a yearly average estimate of -$0.11858. Based on analyst estimates, the high estimate for the next quarter is -$0.03 and the low estimate is -$0.05. The average estimate for the next quarter is thus -$0.04.
